Table 1. Summary of murine xenotransplantation results.

Animals 1–4 were injected with mock-infected HPCs and successfully engrafted. Animals 5–11 were injected with virus-treated HPCs and were successfully engrafted with human cells. Animals 12–17 were injected with virus-treated HPCs but did not successfully engraft. Percents of human and GFP⁺ cells are percents of total peripheral blood leukocytes at 14–18 weeks after transplant.

Animal	Number of cells transplanted	Condition	% Human Leukocytes	% of Human Leukocytes that are GFP+	% of GFP+ Human Leukocytes that are:
					Myeloid	B cells	T cells
1	50,000	Mock	0.6	0.0	-	-	-
2	50,000	Mock	0.1	0.0	-	-	-
3	100,000	Mock	0.1	0.0	-	-	-
4	150,000	Mock	0.1	0.0	-	-	-
5	50,000	7SF-GFP/HXB	0.1	98	16	78	0.0
6	50,000	7SF-GFP/HXB	1.4	100	4.9	92	0.1*
7	100,000	7SF-GFP/HXB	0.4	99	19	56	0.0
8	150,000	7SF-GFP/HXB	9.6	16	6.9	88	0.0
9	150,000	7SF-GFP/HXB	0.5	46	7.7	77	0.0**
10	100,000	7SF-GFP/HXB	1.4	0.0	-	-	-
11	100,000	7SF-GFP/HXB	0.6	0.0	-	-	-
12–17	150,000	7SF-GFP/HXB (No engraftment)	0.0 – 0.03	0.0	-	-	-

^*T cells present at 20 week time point (Figure 6c).

^**T cells present in bone marrow (Figure 6d). See also Figure S4.